Business

Cillian Murphy in Oppenheimer and Margot Robbie as Barbie Julien De Rosa | AFP | Getty Images; Stuart C. Wilson | Getty Images “Barbenheimer” exploded over the weekend, generating an estimated $235.5 million in ticket sales and reinvigorating the domestic box office. “Barbie” tallied around $155 million during its first three days in theaters, the
0 Comments
In this article ABI-BE Follow your favorite stocksCREATE FREE ACCOUNT Republican presidential candidate, Florida Governor Ron DeSantis, delivers remarks at the annual Christians United for Israel Summit (CUFI), at the Crystal Gateway Marriott in Arlington, Virginia, July 17, 2023. Kevin Wurm | Reuters Florida Gov. Ron DeSantis has told his government to investigate whether Bud
0 Comments
In this article Follow your favorite stocksCREATE FREE ACCOUNT Thibaut Mongon, CEO of Kenvue Inc. a Johnson & Johnson’s consumer-health business, speaks during an interview to celebrate its IPO at the New York Stock Exchange (NYSE), May 4, 2023. Brendan Mcdermid | Reuters Most consumers have pulled back on spending as inflation squeezes their wallets,
0 Comments
In this article AAL UAL DAL Follow your favorite stocksCREATE FREE ACCOUNT An American Airlines 777 is loaded with cargo at Philadelphia International Airport. Leslie Josephs/CNBC Airlines’ cargo revenue is slumping. That’s a sign of good news for travel recovery. Delta, United and American this month each reported year-over-year declines of about 40% in their
0 Comments
Major League Soccer’s hottest new star is already paying off for Inter Miami. All-time soccer great Lionel Messi’s arrival is expected to double the club’s revenues over the next 12 months, its managing owner Jorge Mas told CNBC’s “Halftime Report.” The Argentina national and former Barcelona star joined Inter Miami on Monday. related investing news
0 Comments
In this article JNJ Follow your favorite stocksCREATE FREE ACCOUNT Pavlo Gonchar | LightRocket | Getty Images Johnson & Johnson on Tuesday sued the Biden administration over Medicare’s new powers to slash drug prices, making it the third pharmaceutical company to challenge the controversial provision of the Inflation Reduction Act.   The lawsuit filed in federal
0 Comments